![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/harmony-biosciences-acknowledges-us-food--drug-administration-fda-action-denying-the-citizen-petition-for-wakix-pitolsiant-302181609.html
https://www.prnewswire.com/news-releases/harmony-biosciences-receives-us-food-and-drug-administration-approval-for-wakix-pitolisant-in-pediatric-patients-with-narcolepsy-302179754.html
https://www.prnewswire.com/news-releases/harmony-biosciences-acquires-epygenix-therapeutics-inc-adding-late-stage-epilepsy-franchise-to-growing-pipeline-of-innovative-cns-assets-302131000.html
https://www.globenewswire.com/news-release/2024/04/30/2872080/0/en/Harmony-Biosciences-Reports-Strong-First-Quarter-Financial-Results-and-Acceleration-of-Its-Growth-Strategy-Advances-Pitolisant-Franchise-to-Extend-Revenue-Potential-Beyond-2040-Str.html
https://www.prnewswire.com/news-releases/harmony-biosciences-announces-exclusive-agreement-to-develop-and-commercialize-tpm-1116-a-highly-potent-and-selective-oral-orexin-2-receptor-agonist-302113794.html
https://www.prnewswire.com/news-releases/harmony-biosciences-initiates-global-phase-3-registrational-trial-tempo-study-of-pitolisant-in-patients-with-prader-willi-syndrome-302106423.html
https://ir.harmonybiosciences.com/news-releases/news-release-details/harmony-biosciences-participate-23rd-annual-needham-virtual
https://ir.harmonybiosciences.com/news-releases/news-release-details/harmony-biosciences-certified-great-place-workr-sixth
https://www.globenewswire.com//news-release/2024/02/22/2833569/0/en/Harmony-Biosciences-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Business-Updates.html
https://www.prnewswire.com/news-releases/harmony-biosciences-receives-us-food-and-drug-administration-orphan-drug-designation-for-pitolisant-in-prader-willi-syndrome-302065480.html